Darana Yuen1, Yvonne M Buys. 1. Toronto Western Hospital, University of Toronto, 399 Bathurst Street, East Wing 6-405, Toronto, Ontario, M5T 2S8, Canada.
Abstract
BACKGROUND: Reversal of cupping is a widely recognized phenomenon. However, whether or not functional improvement is associated with reversal of cupping is controversial. There has not been any documentation in the literature of reversal of cupping with accompanying Heidelberg Retinal Tomograph (HRT) images and visual field (VF) changes at each time point. METHODS: Case report based on one patient. RESULTS: Reversible cupping was seen following a dramatic reduction of IOP post-trabeculectomy, which was associated with an improved HRT but unchanged VF. CONCLUSIONS: This case documents reversal of cupping with VF and HRT testing accompanying the disc photos at each time point. Despite improvement in disc appearance and on structural testing, functional testing was unchanged.
BACKGROUND: Reversal of cupping is a widely recognized phenomenon. However, whether or not functional improvement is associated with reversal of cupping is controversial. There has not been any documentation in the literature of reversal of cupping with accompanying Heidelberg Retinal Tomograph (HRT) images and visual field (VF) changes at each time point. METHODS: Case report based on one patient. RESULTS: Reversible cupping was seen following a dramatic reduction of IOP post-trabeculectomy, which was associated with an improved HRT but unchanged VF. CONCLUSIONS: This case documents reversal of cupping with VF and HRT testing accompanying the disc photos at each time point. Despite improvement in disc appearance and on structural testing, functional testing was unchanged.
Authors: M R Lesk; G L Spaeth; A Azuara-Blanco; S V Araujo; L J Katz; A K Terebuh; R P Wilson; M R Moster; C M Schmidt Journal: Ophthalmology Date: 1999-05 Impact factor: 12.079
Authors: Richard K Parrish; William J Feuer; Joyce C Schiffman; Paul R Lichter; David C Musch Journal: Am J Ophthalmol Date: 2009-01-18 Impact factor: 5.258
Authors: Andrew J Tatham; Robert N Weinreb; Linda M Zangwill; Jeffrey M Liebmann; Christopher A Girkin; Felipe A Medeiros Journal: Invest Ophthalmol Vis Sci Date: 2013-05-07 Impact factor: 4.799